FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q4 2022

Top Holdings243 positions

Checking export access…
Activity:
SPYSPY
PUT

STATE STR SPDR S&P 500 ETF T

3.8M$1.5B8.6%———
Decreased
—

IQVIA HLDGS INC

3.3M$667.6M3.9%$146.64+39.72%
17 qtrssince 2018-Q4
Increased
59

THERMO FISHER SCIENTIFIC INC

1.2M$639.9M3.8%$398.80+36.48%
13 qtrssince 2019-Q4
Increased
60

TRANSUNION

8.9M$503M3.0%$86.82-35.70%
17 qtrssince 2018-Q4
Increased
60

SALESFORCE INC

3.8M$501.3M3.0%$163.73-20.54%
13 qtrssince 2019-Q4
Increased
83

ARAMARK

10.8M$447.7M2.6%$24.80+15.63%
9 qtrssince 2020-Q4
Decreased
0

BOSTON SCIENTIFIC CORP

9.3M$428.5M2.5%$38.68+19.62%
10 qtrssince 2020-Q3
Decreased
0

HORIZON THERAPEUTICS PUB L

3.7M$420.5M2.5%——
7 qtrssince 2021-Q2
Increased
86

MICROSOFT CORP

1.7M$404.9M2.4%$159.58+45.85%
17 qtrssince 2018-Q4
Increased
62
AZNAZN
ADR

ASTRAZENECA PLC

5.9M$398.4M2.4%$114.74+11.36%
6 qtrssince 2021-Q3
Increased
56

CENTENE CORP DEL

4.6M$376.6M2.2%$62.63+30.95%
12 qtrssince 2020-Q1
Increased
58

S&P GLOBAL INC

1.1M$360.8M2.1%$297.14+3.32%
3 qtrssince 2022-Q2
Increased
74

ACTIVISION BLIZZARD INC

4.6M$355.2M2.1%——
4 qtrssince 2022-Q1
Increased
59

INTUIT

902,100$351.1M2.1%$380.880.00%
1 qtr
New
80
YMMYMM
ADR

FULL TRUCK ALLIANCE CO LTD

43.4M$347.5M2.1%$7.80-3.22%
7 qtrssince 2021-Q2
Decreased
0

EQUIFAX INC

1.7M$330.9M2.0%$192.36-1.09%
17 qtrssince 2018-Q4
Decreased
0

SHERWIN WILLIAMS CO

1.4M$328.9M1.9%$172.69+32.81%
16 qtrssince 2019-Q1
Increased
53

ELEVANCE HEALTH INC FORMERLY

634,300$325.4M1.9%$291.80+68.01%
17 qtrssince 2018-Q4
Decreased
0

HOWMET AEROSPACE INC

8.1M$319.5M1.9%$28.78+35.42%
11 qtrssince 2020-Q2
Decreased
0

MASTERCARD INCORPORATED

916,171$318.6M1.9%$342.92-0.85%
8 qtrssince 2021-Q1
Decreased
0
$16.9B
AUM
243
Positions
Q4 2022
Filing
HI score · 1.0/5
Quarterly 13F Value Change
-13%Q3'21$21.4B-7%Q4'21$20B+3%Q1'22$20.7B-11%Q2'22$18.4B-1%Q3'22$18.2B-7%Q4'22$16.9B
Activity profile
$ moved · Q4'22
New8%Increased32%Decreased19%Exited42%
Composition
Equity vs derivatives
Equity91%Puts9%Calls0%
Holding period
Avg 1.6 years
<1Q5%1-4Q23%1-2Y49%2Y+24%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $16.9B across 243 positions as of Q4 2022. Top holdings: SPY puts (8.6%), IQV (3.9%), TMO (3.8%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.

Q4 2022 Summary

Active quarter - 15 new positions, 82 exits, 43 increased. Top move: HZNP (INCREASED, conviction 86). Portfolio: $16.9B across 243 positions.

Top holdings by portfolio weight

Total AUM$15B
IQV3.94%
TMO3.78%
TRU2.97%
CRM2.96%
ARMK2.64%
BSX2.53%
HZNP2.48%
MSFT2.39%
AZN2.35%
CNC2.22%
Other2.13%

Portfolio allocation by GICS sector

Sectors11
Healthcare33.45%
Technology18.44%
Unknown14.62%
Financial Services14.10%
Industrials9.76%
Communication Services3.25%
Basic Materials2.29%
Real Estate1.79%
Consumer Cyclical1.63%
Utilities0.59%
Other0.06%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Technology, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L45
Conviction44
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 → Q2 2026+9M shares+$755.7M
7Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q4 2024 → Q2 2026+7.8M shares+$277M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 → Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used